The FDA's inexcusable foot-dragging on child vaccination
The new school year is fertile ground for the Delta variant to spread
Many American parents are extremely anxious about returning their kids to school amid the resurgent COVID-19 pandemic — which is especially frustrating because the country is swimming in vaccines. Yet instead of scrambling to issue an emergency use authorization so children can get vaccinated, the FDA has asked Pfizer and Moderna to greatly expand the sample size of their clinical trials for children, which will likely push back initial approval by months, into midwinter.
This is unacceptable. The Food and Drug Administration already has data on kids aged between 5-11, and should issue emergency authorization for all children under 12 as soon as possible, so long as that data shows an acceptably low risk of complications. Dithering to understand very rare side effects is simply bad risk management with the Delta variant spreading like wildfire.
The reason the FDA is asking for more data is concerns over rare side effects, myocarditis and pericarditis (types of inflammation of the heart) that were seen in a few young people in Israel and the elsewhere. The worry is that younger kids might be at higher risk due to differences in their immune systems. In the abstract, that makes sense — obviously in ideal conditions one would want the best possible data on what the vaccines do in kids. We should be cautious when approving new treatments for children.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But we are just as obviously not in ideal conditions. The pandemic is absolutely out of control in many southern states, and even in heavily-vaccinated states cases are still rising. Meanwhile, the school year is close to starting or has already started across much of the country, and school districts in many conservative states are in an open battle with their state governments over the right to have even slight protections in the classroom. Texas Governor Greg Abbott and Florida Governor Ron DeSantis are both in court over this question.
Even so, whatever protections schools do set up will likely be inadequate, given how cash-strapped American schools tend to be and the extreme contagiousness of the Delta variant. Sure enough, when schools have started with in-person instruction, instantaneous gigantic outbreaks have commonly been the result. Some 121,000 COVID cases were reported among children last week, and a record 1,900 kids are currently hospitalized. Multiple cities have run out of pediatric ICU beds.
So the FDA is facing a tough choice. The raging pandemic means there is no way to avoid risk: Either approve the vaccine for kids aged 5-11 right away, chancing that a few kids will come down with complications, or sit back and let most of them get COVID. The correct choice will depend on which option causes less harm.
Obviously I am not an expert in the science of what mRNA vaccines might do in kids. But multiple credentialed doctors and epidemiologists have argued that the data the FDA already has is enough to make an educated guess, and that vaccination will almost certainly be far, far safer than COVID. In Israel, the risk of myocarditis was roughly between one in 3000 and one in 6000 for men between 16 and 24 (the highest-risk group), and all but two of them recovered. "Ninety-nine percent of the experts in this area are convinced these vaccines are absolutely safe in children and adults from what we've seen," Dr. Yvonne Maldonado, a Stanford professor of pediatric diseases, told Michelle Goldberg at The New York Times.
Pediatrician Aaron E. Carroll writes that he is confident enough in the vaccines that if his kids were younger, he would have them vaccinated at the earliest possible moment, because COVID is no joke even for kids:
The American Academy of Pediatrics wrote an open letter to the FDA making the same argument I have above. "The FDA should strongly consider authorizing these vaccines for children ages 5-11 years based on data from the initial enrolled cohort, which are already available, while continuing to follow safety data from the expanded cohort in the post-market setting," they wrote.
But perhaps the strongest argument for child vaccination has to do with adults and society as a whole. Kids are a big hole in the vaccination wall — there are about 31 million people aged between 5 and 11 years old, or about 10 percent of the population (and another 6 percent between 0-4). Practically speaking, that means it is impossible for even the most-vaccinated states to get up to the 85-90 percent vaccination rate scientists estimate is probably necessary for Delta to die out. Until we can vaccinate kids, the pandemic is going to keep burning for months, even in Vermont.
What's more, unlike single adults or childless couples, almost all kids live in larger households, which necessarily means greater risk of transmission — particularly with Delta. Sure enough, a recent study found that kids can easily get COVID from school (or other activities) and spread it around their household. To the probable benefits of children avoiding sickness and death must be added the benefits of reduced risk for their family members and friends.
At any rate, while I may not be an epidemiologist, I know bureaucratic rear-covering when I see it. When a microscopic handful of people got a rare blood-clotting side effect as a result of the Johnson & Johnson vaccine, the FDA issued a pause on its use — showing a wildly disproportionate sensitivity towards vaccine-caused illness as compared to that caused by COVID, which is indeed much, much worse.
For whatever reason, bureaucrats often seem to believe that the worst kind of failure is when the government takes some action and bad things happen. Bad things happening because the government didn't take swift action doesn't register in the same way. But the truth is that if the FDA has sufficient evidence to know that vaccinating kids will make them and the American people safer on net, and they refuse to do so, they will be directly responsible for a tremendous amount of unnecessary illness and death.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Ryan Cooper is a national correspondent at TheWeek.com. His work has appeared in the Washington Monthly, The New Republic, and the Washington Post.
-
Today's political cartoons - December 21, 2024
Cartoons Saturday's cartoons - losing it, pedal to the metal, and more
By The Week US Published
-
Three fun, festive activities to make the magic happen this Christmas Day
Inspire your children to help set the table, stage a pantomime and write thank-you letters this Christmas!
By The Week Junior Published
-
The best books of 2024 to give this Christmas
The Week Recommends From Percival Everett to Rachel Clarke these are the critics' favourite books from 2024
By The Week UK Published
-
Jay Bhattacharya: another Covid-19 critic goes to Washington
In the Spotlight Trump picks a prominent pandemic skeptic to lead the National Institutes of Health
By David Faris Published
-
US election: who the billionaires are backing
The Explainer More have endorsed Kamala Harris than Donald Trump, but among the 'ultra-rich' the split is more even
By Harriet Marsden, The Week UK Published
-
US election: where things stand with one week to go
The Explainer Harris' lead in the polls has been narrowing in Trump's favour, but her campaign remains 'cautiously optimistic'
By Harriet Marsden, The Week UK Published
-
Is Trump okay?
Today's Big Question Former president's mental fitness and alleged cognitive decline firmly back in the spotlight after 'bizarre' town hall event
By Harriet Marsden, The Week UK Published
-
The life and times of Kamala Harris
The Explainer The vice-president is narrowly leading the race to become the next US president. How did she get to where she is now?
By The Week UK Published
-
Bob Woodward's War: the explosive Trump revelations
In the Spotlight Nobody can beat Watergate veteran at 'getting the story of the White House from the inside'
By Chas Newkey-Burden, The Week UK Published
-
Trump kept up with Putin, sent Covid tests, book says
Speed Read The revelation comes courtesy of a new book by Bob Woodward
By Peter Weber, The Week US Published
-
Will 'weirdly civil' VP debate move dial in US election?
Today's Big Question 'Diametrically opposed' candidates showed 'a lot of commonality' on some issues, but offered competing visions for America's future and democracy
By Harriet Marsden, The Week UK Published